Felicia Tan Published on Fri, Jun 04, 2021 

Q&M’s 51%-owned subsidiary Acumen Diagnostics have been granted approval by the Ministry of Health (MOH) to provide offsite Covid-19 Polymerase Chain Reaction (PCR) swab and serology services on June 2.This means Acumen will be able to provide Covid-19 PCR swab and serology services to members of the public at approved premises.The offsite testing will take place at the former Siglap Secondary School, as well as other sites approved by the Health Promotion Board (HPB) from June 2 to June 1, 2023.Shares in Q&M closed 1 cent lower or 1.4% down at 68 cents on June 4.